PUBLICATIONS
2020
2.
Sunyong Yoo; Hyung Chae Yang; Seongyeong Lee; Jaewook Shin; Seyoung Min; Eunjoo Lee; Minkeun Song; Doheon Lee
Abstract | Links | BibTeX | Dimensions | Tags: Bioinformatics, Chemical property, Deep learning, Molecular interaction, Natural product, Network analysis, Text mining
@article{10.3389/fphar.2020.584875,
title = {A Deep Learning-Based Approach for Identifying the Medicinal Uses of Plant-Derived Natural Compounds},
author = {Sunyong Yoo and Hyung Chae Yang and Seongyeong Lee and Jaewook Shin and Seyoung Min and Eunjoo Lee and Minkeun Song and Doheon Lee},
url = {https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.584875},
doi = {10.3389/fphar.2020.584875},
issn = {1663-9812},
year = {2020},
date = {2020-01-01},
urldate = {2020-01-01},
journal = {Frontiers in Pharmacology},
volume = {11},
pages = {584875},
abstract = {Medicinal plants and their extracts have been used as important sources for drug discovery. In particular, plant-derived natural compounds, including phytochemicals, antioxidants, vitamins, and minerals, are gaining attention as they promote health and prevent disease. Although several in vitro methods have been developed to confirm the biological activities of natural compounds, there is still considerable room to reduce time and cost. To overcome these limitations, several in silico methods have been proposed for conducting large-scale analysis, but they are still limited in terms of dealing with incomplete and heterogeneous natural compound data. Here, we propose a deep learning-based approach to identify the medicinal uses of natural compounds by exploiting massive and heterogeneous drug and natural compound data. The rationale behind this approach is that deep learning can effectively utilize heterogeneous features to alleviate incomplete information. Based on latent knowledge, molecular interactions, and chemical property features, we generated 686 dimensional features for 4,507 natural compounds and 2,882 approved and investigational drugs. The deep learning model was trained using the generated features and verified drug indication information. When the features of natural compounds were applied as input to the trained model, potential efficacies were successfully predicted with high accuracy, sensitivity, and specificity.},
keywords = {Bioinformatics, Chemical property, Deep learning, Molecular interaction, Natural product, Network analysis, Text mining},
pubstate = {published},
tppubtype = {article}
}
Medicinal plants and their extracts have been used as important sources for drug discovery. In particular, plant-derived natural compounds, including phytochemicals, antioxidants, vitamins, and minerals, are gaining attention as they promote health and prevent disease. Although several in vitro methods have been developed to confirm the biological activities of natural compounds, there is still considerable room to reduce time and cost. To overcome these limitations, several in silico methods have been proposed for conducting large-scale analysis, but they are still limited in terms of dealing with incomplete and heterogeneous natural compound data. Here, we propose a deep learning-based approach to identify the medicinal uses of natural compounds by exploiting massive and heterogeneous drug and natural compound data. The rationale behind this approach is that deep learning can effectively utilize heterogeneous features to alleviate incomplete information. Based on latent knowledge, molecular interactions, and chemical property features, we generated 686 dimensional features for 4,507 natural compounds and 2,882 approved and investigational drugs. The deep learning model was trained using the generated features and verified drug indication information. When the features of natural compounds were applied as input to the trained model, potential efficacies were successfully predicted with high accuracy, sensitivity, and specificity.
2018
1.
Sunyong Yoo; Kwansoo Kim; Hojung Nam; Doheon Lee
Abstract | Links | BibTeX | Dimensions | Tags: Bioinformatics, Chemical property, Ethnopharmacology, Herbal medicine, Molecular analysis, Network analysis, Phytochemical
@article{yoo2018discovering,
title = {Discovering health benefits of phytochemicals with integrated analysis of the molecular network, chemical properties and ethnopharmacological evidence},
author = {Sunyong Yoo and Kwansoo Kim and Hojung Nam and Doheon Lee},
url = {https://www.mdpi.com/2072-6643/10/8/1042},
doi = {10.3390/nu10081042},
year = {2018},
date = {2018-08-08},
urldate = {2018-08-08},
journal = {Nutrients},
volume = {10},
number = {8},
pages = {1042},
publisher = {MDPI},
abstract = {Identifying the health benefits of phytochemicals is an essential step in drug and functional food development. While many in vitro screening methods have been developed to identify the health effects of phytochemicals, there is still room for improvement because of high cost and low productivity. Therefore, researchers have alternatively proposed in silico methods, primarily based on three types of approaches; utilizing molecular, chemical or ethnopharmacological information. Although each approach has its own strength in analyzing the characteristics of phytochemicals, previous studies have not considered them all together. Here, we apply an integrated in silico analysis to identify the potential health benefits of phytochemicals based on molecular analysis and chemical properties as well as ethnopharmacological evidence. From the molecular analysis, we found an average of 415.6 health effects for 591 phytochemicals. We further investigated ethnopharmacological evidence of phytochemicals and found that on average 129.1 (31%) of the predicted health effects had ethnopharmacological evidence. Lastly, we investigated chemical properties to confirm whether they are orally bio-available, drug available or effective on certain tissues. The evaluation results indicate that the health effects can be predicted more accurately by cooperatively considering the molecular analysis, chemical properties and ethnopharmacological evidence.},
keywords = {Bioinformatics, Chemical property, Ethnopharmacology, Herbal medicine, Molecular analysis, Network analysis, Phytochemical},
pubstate = {published},
tppubtype = {article}
}
Identifying the health benefits of phytochemicals is an essential step in drug and functional food development. While many in vitro screening methods have been developed to identify the health effects of phytochemicals, there is still room for improvement because of high cost and low productivity. Therefore, researchers have alternatively proposed in silico methods, primarily based on three types of approaches; utilizing molecular, chemical or ethnopharmacological information. Although each approach has its own strength in analyzing the characteristics of phytochemicals, previous studies have not considered them all together. Here, we apply an integrated in silico analysis to identify the potential health benefits of phytochemicals based on molecular analysis and chemical properties as well as ethnopharmacological evidence. From the molecular analysis, we found an average of 415.6 health effects for 591 phytochemicals. We further investigated ethnopharmacological evidence of phytochemicals and found that on average 129.1 (31%) of the predicted health effects had ethnopharmacological evidence. Lastly, we investigated chemical properties to confirm whether they are orally bio-available, drug available or effective on certain tissues. The evaluation results indicate that the health effects can be predicted more accurately by cooperatively considering the molecular analysis, chemical properties and ethnopharmacological evidence.